Comparative hepatoprotective effects of tocotrienol analogs against drug-induced liver injury

Redox Biol. 2015;4:308-20. doi: 10.1016/j.redox.2015.01.013. Epub 2015 Jan 20.

Abstract

Oxidative stress plays a major part in the pathogenesis of drug-induced liver injury. Yet, overcoming it with other xenobiotics impose additional risks. In this study, we consider the use of natural-occurring and purified Vitamin E analogs as hepatoprotective agents. Vitamin E is well-known for its intrinsic antioxidant property even though the differential effect of specific analogs of tocopherol (TP) and tocotrienol (T3) is still not ascertained. This study investigates the protective effect of T3 analogs (α-, δ-, γ-) in comparison with α-TP followed by assessing the underlying mechanisms of the cytoprotective T3 analog(s) in two xenobiotics-induced liver injury models using (1) acetaminophen (APAP)- and (2) hydrogen peroxide (H2O2). Both α-TP and α-T3 exerted cytoprotective effects while only lower concentration of γ-T3 was effective in inhibiting both toxicants induced injury. α-TP/α-T3 protected hepatocytes from APAP and H2O2-induced liver injury through arresting free radicals and inhibiting oxidative stress (inhibition of reactive oxygen species, lipid peroxidation and mitochondrial permeability transition). There was also demonstrable inhibition of the apoptotic pathway (inhibition of caspse-3 activity and overexpression of Bcl-XL), accompanied with an induction of liver regeneration (PCNA and NF-kB). The cellular uptake of α-T3 was higher than α-TP at the same treatment dosage after 24h. Overall, α-T3 seems to be a more potent hepatoprotective analog among the tocotrienols and α-TP at the same in vitro treatment dosage. In summary, these results suggest that α-TP/α-T3 elicit hepatoprotective effects against toxicants-induced damage mainly through activation of antioxidant responses at an early stage to prevent the exacerbation of injury.

Keywords: Antioxidant; Drug-induced liver injury; Tocopherol; Tocotrienol.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetaminophen / antagonists & inhibitors
  • Acetaminophen / toxicity
  • Animals
  • Antioxidants / pharmacology*
  • Caspase 3 / genetics
  • Caspase 3 / metabolism
  • Cell Line, Transformed
  • Cell Survival / drug effects
  • Gene Expression Regulation
  • Hepatocytes / cytology
  • Hepatocytes / drug effects*
  • Hepatocytes / metabolism
  • Hydrogen Peroxide / antagonists & inhibitors
  • Hydrogen Peroxide / toxicity
  • Interleukin-6 / genetics
  • Interleukin-6 / metabolism
  • Lipid Peroxidation / drug effects
  • Mice
  • Mitochondria / drug effects*
  • Mitochondria / metabolism
  • Nitric Oxide Synthase Type II / genetics
  • Nitric Oxide Synthase Type II / metabolism
  • Oxidative Stress / drug effects
  • Proliferating Cell Nuclear Antigen / genetics
  • Proliferating Cell Nuclear Antigen / metabolism
  • Protective Agents / pharmacology*
  • Reactive Oxygen Species / antagonists & inhibitors
  • Reactive Oxygen Species / metabolism
  • Signal Transduction
  • Tocopherols / pharmacology*
  • Tumor Necrosis Factor-alpha / genetics
  • Tumor Necrosis Factor-alpha / metabolism
  • Vitamin E / pharmacology*
  • bcl-X Protein / genetics
  • bcl-X Protein / metabolism

Substances

  • Antioxidants
  • Bcl2l1 protein, mouse
  • Interleukin-6
  • Proliferating Cell Nuclear Antigen
  • Protective Agents
  • Reactive Oxygen Species
  • Tumor Necrosis Factor-alpha
  • bcl-X Protein
  • interleukin-6, mouse
  • Vitamin E
  • Acetaminophen
  • Hydrogen Peroxide
  • Nitric Oxide Synthase Type II
  • Nos2 protein, mouse
  • Caspase 3
  • Tocopherols